BCRL Prevention Pilot
The purpose of this study is to establish feasiblity of recruiting obese breast cancer survivors at the end of treatment, getting those survivors to lose weight and attend follow-up visits for 6 months.
|Study Design:||Observational Model: Cohort|
|Official Title:||Weight Loss to Prevent BCRL: A Pilot Study|
- Follow-up Appts. [ Time Frame: 6 months ] [ Designated as safety issue: No ]The primary outcome will be the precent of participants who complete 6 month follow-up appointments.
- Response Rates [ Time Frame: 6 months ] [ Designated as safety issue: No ]Secondary outcomes will include response rates (% approached who enroll, consent, and attend intervention sessions), weight loss at 6 months, and arm volumes and lymphedema survey responses at 6 months.
|Study Start Date:||July 2010|
|Study Completion Date:||October 2012|
|Primary Completion Date:||October 2012 (Final data collection date for primary outcome measure)|
Breast cancer related lymphedema occurs in 20-30% of survivors. Weight loss could prevent onset. We seek to do a pilot study to establish feasibility of 1) recruiting survivors at risk for lymphedema to do a weight loss intervention, 2) achieving 10-15% weight loss over 26 weeks in this population, and 3) attendance at follow-up visits 6 months.
Please refer to this study by its ClinicalTrials.gov identifier: NCT01166672
|United States, Pennsylvania|
|Abramson Cancer Center of the University of Pennsylvania|
|Philadelphia, Pennsylvania, United States, 19104|